Your browser doesn't support javascript.
loading
Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience.
Cavanna, Luigi; Stroppa, Elisa Maria; Citterio, Chiara; Mordenti, Patrizia; Di Nunzio, Camilla; Peveri, Silvia; Orlandi, Elena; Vecchia, Stefano.
Afiliación
  • Cavanna L; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Stroppa EM; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Citterio C; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Mordenti P; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Di Nunzio C; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Peveri S; Allergology and Statistics Unit, Piacenza General Hospital, Piacenza, Italy.
  • Orlandi E; Oncology and Hematology Department, Oncology Unit, Piacenza General Hospital, Piacenza, Italy.
  • Vecchia S; Pharmacy Unit, Piacenza General Hospital, Piacenza, Italy.
Onco Targets Ther ; 12: 3077-3085, 2019.
Article en En | MEDLINE | ID: mdl-31118666
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Onco Targets Ther Año: 2019 Tipo del documento: Article País de afiliación: Italia